ArticleTranslational lung cancer research2021

Randomized phase II trial of a first-in-human cancer cell lysate vaccine in patients with thoracic malignancies.

Mary Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.